Virax Biolabs is an England-based biotechnology company that offers solutions such as immunology profiling and testing for the healthcare industry.
Business Model:
Revenue: $123.8k
Employees: 2-10
Address: 20 North Audley Street
City: London
State: england
Zip: W1K 6LX
Country: GB
Virax Biolabs is an England-based biotechnology company that offers solutions such as immunology profiling and testing for the healthcare industry.
Contact Phone:
Contact Email:
Listed Exchange:
NASDAQ
IPO Date:
7/21/2022
IPO Valuation:
$57M
Ticker Symbol:
VRAX
IPO Price:
$5/share
Amount Raised:
$7M
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 11/2022 | Private Placement | $3.8M | 3/2016 | Pre Seed Round | $500k | 9/2018 | Pre Seed Round | $1M | 3/2020 | Series A | $1.5M | 3/2013 | Pre Seed Round | $1M | 11/2022 | Private Placement | $3.8M | 3/2022 | IPO | $6.8M |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|